Press Releases Archives - Page 20 of 103 - Lupin

BSE 2328.10 NSE 2324.50

indian flag icon

India

USA

great-britain flag icon

UK

south-africa flag icon

South Africa

australia flag icon

Australia

philippines flag icon

Philippines

germany flag icon

Germany

netherlands flag icon

Netherlands

mexico flag icon

Mexico

brazil flag icon

Brazil

canada flag icon

Canada

Switzerland flag icon

Switzerland

BSE 2328.10 NSE 2324.50

Lupin and Zydus Sign Licensing Agreement for Co-marketing Saroglitazar Mg, a critical treatment for chronic liver diseases in India

November 3, 2023

Lupin Launches Diazepam Rectal Gel in the United States

November 2, 2023

Lupin Receives Tentative Approval from U.S. FDA for Selexipag for Injection

November 2, 2023

Lupin Receives EIR from U.S. FDA for its Mandideep Unit-2 Manufacturing Facility

October 31, 2023

Lupin Receives Approval from U.S.FDA for Fluconazole Tablets, USP

October 23, 2023

Lupin Receives Tentative Approval from U.S. FDA for Apalutamide Tablets

October 13, 2023

Lupin Receives Tentative Approval from U.S. FDA for Calcium, Magnesium, Potassium, and Sodium Oxybates Oral Solution

October 13, 2023

Lupin Receives Tentative Approval from U.S. FDA for Tolvaptan Tablets

October 5, 2023

Lupin Launches Humrahi Unique Patient Support Program for Diabetes Management

October 3, 2023

Lupin Receives EIR from U.S. FDA for its Nagpur Unit-1 Manufacturing Facility

September 29, 2023

1 2 … 19 20 21 … 102 103

Search

Hit enter to search or ESC to close